October 24, 2016 11:19 AM ET

Life Sciences Tools and Services

Company Overview of Covance Inc.

Key Executives for Covance Inc.

NameBoard RelationshipsTitleAge
Deborah L. Keller Tanner No RelationshipsChief Executive Officer53
Richard F. Cimino 26 RelationshipsExecutive Vice President and Group President of Clinical Development Services56
Jonathan Koch No RelationshipsCorporate Vice President and President of Central Laboratory Services--
John E. Watson No RelationshipsPresident of Strategic Partnering, Chief Commercial Officer, Corporate Senior Vice President56
Steven M. Anderson Ph.D.11 RelationshipsChief Scientific Officer and Senior Vice President of Labcorp--
View More Key Executives

Covance Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Joseph L. Herring 21 RelationshipsHenry Schein, Inc.60
Sandra L. Helton 32 RelationshipsPrincipal Financial Group Inc.66
Joseph C. Scodari 128 RelationshipsThe Pennsylvania Biotechnology Association63
Bradley T. Sheares Ph.D. 41 RelationshipsProgressive Corp.59
Robert L. Barchi M.D., Ph.D. 32 RelationshipsRutgers, The State University of New Jersey69
View All Board Members

Covance Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Sandra L. Helton32 Relationships3 Executives
Compensation Committee Ph.D.Bradley T. Sheares41 Relationships3 Executives
Corporate Governance Committee Joseph C. Scodari128 Relationships3 Executives
Finance Committee Sandra L. Helton32 Relationships3 Executives
Management/Organization Development Committee Ph.D.Bradley T. Sheares41 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$2.6M
Total Value of Options$455.5K
Compensation as of Fiscal Year 2013
Covance Inc. CEO Compensation
Industry Average


Cromos™ Pharma Appoints Gearóid Tuohy as Vice President, International Business and Operations
October 24, 2016 6:36 AM ET
Liberty Biopharma Announces the Appointment of Dr. Hon-Kan Yip as Medical Advisor
October 20, 2016 6:13 PM ET
ICON Announces Executive Changes, Effective 1 March 2017
October 20, 2016 8:15 AM ET
PureTech Health plc Appoints Joseph Bolen, Ph.D., as Chief Scientific Officer
October 20, 2016 6:00 AM ET
Fluidigm Corporation Announces Management Changes
October 19, 2016 9:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Covance Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.